楼主 (北美华人网)
The study, published online April 22 in the Journal of Allergy and Clinical Immunology, suggests a possible reason why people with respiratory allergy and asthma do not seem to experience some of the more severe and life-threatening manifestations of the COVID-19 disease. Importantly, previous studies have shown that higher expression of ACE2 is associated with smoking, diabetes, and hypertension — all of which are known risk factors for COVID-19 disease severity. https://www.jacionline.org/action/showPdf?pii=S0091-6749%2820%2930551-0